CSPC Pharmaceutical Group Limited 1093.HK HKSE · Healthcare · China
$8.03 -4.41% -$0.37
Summary
80 / 100 · Bulios Score
What speaks for it
- Out of every 100 CNY of revenue, 24 CNY is left as net profit.
- It holds more cash than debt: ¥10.00B against ¥652.4M.
- It earns 17 CNY a year on every 100 CNY of invested capital.
- The share price is below the Bulios Fair Price.
What to watch
- Revenue fell by 7.1% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 11.1 CNY for 1 CNY of yearly profit. Over the last five years it was 15.4 CNY on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (CNY)
Diluted EPS (CNY)
- Analyst estimate
Revenue grew by 1.4% a year over 5 years. Over the last 3 years it fell by 7.1% a year. For the next fiscal year analysts expect revenue to grow by 32%. Earnings per share fell by 14% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 CNY of revenue goes
- Cost of sales 28 CNY
- Research and development 20 CNY
- Sales and administration 24 CNY
- Taxes and other 4.2 CNY
- Net profit 24 CNY
Net profit, industry median (Drug Manufacturers - General) 14 CNY
Out of every 100 CNY of revenue, 24 CNY is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 3.94%
- Paid out of profit
- 44%
You receive $0.33 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail